XAVINE

Live / Registered — Registered (as of 26 Mar 2024)

What this means for you

Registered since 26 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88216620
Registration number
7340137
Mark type
Stylized text
Filed
04 Dec 2018
Published for opposition
08 Oct 2019
Registered
26 Mar 2024

Goods and services

  • Class 005 — Pharmaceuticals: A vaccine that is used to treat or prevent an autoimmune disease, an allergy, or a food sensitivity by turning down specific immune responses in humans or animals

Owner

Prosecution history

  • 26 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 26 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
  • 20 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 19 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 07 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 07 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 07 Feb 2024 — ASSIGNED TO LIE
  • 09 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 09 Nov 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 09 Nov 2022 — NON-FINAL ACTION E-MAILED
  • 09 Nov 2022 — SU - NON-FINAL ACTION - WRITTEN
  • 02 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
  • 19 Oct 2022 — USE AMENDMENT FILED
  • 19 Oct 2022 — TEAS STATEMENT OF USE RECEIVED
  • 30 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

View this trademark record on Marksy